Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measuring the Efficacy of Paxman Scalp Cooling to Prevent Chemotherapy Induced Alopecia (CIA) in Black Patients With Stage I-III Breast or Gynecological Cancers

NCT04626895 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT04626895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measuring the Efficacy of Paxman Scalp Cooling to Prevent Chemotherapy Induced Alopecia (CIA) in Black Patients With Stage I-III Breast or Gynecological Cancers
Lead sponsor
Medstar Health Research Institute
Phase
Not applicable
Overall status
Completed
Start date
June 4, 2019
Completion date
October 1, 2020
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, endometrial cancer, gynecologic neoplasm, ovarian cancer